Generic Drug Industry Market Research Reports, June 2013

Company Report: Generic Drug in India, Japan and The United States for Year 2013

• Company report
• June 2013
• 4 pages

... For developing and manufacturing generic drugs in japan. However, as fujifilm realigns its long-term growth strategy for the pharmaceutical business, both companies have led to a mutual agreement to terminate ...

• Industries: Generic Drug
• Countries: India, Japan, United States

Company Report: Generic Drug in Europe and The United States for Year 2013

• Company report
• May 2013
• 10 pages

• Industries: Generic Drug
• Countries: Italy, Europe, United States

Generic Drug in The United Kingdom : Innovation and Technology Trends

• Industry report
• May 2013
• 2 pages

... Including on truly new medicines developed to address unmet patient needs. Additionally, generic medicines, which are manufactured to the same standards of safety, quality and efficacy as their originator ...

• Industries: Generic Drug
• Countries: United Kingdom

Company Report: Generic Drug in Singapore, South Korea and The United States for Year 2013

• Company report
• April 2013
• 3 pages
• by Corporation

• Industries: Generic Drug
• Countries: Singapore, South Korea, United States

Company Report: Generic Drug in India for Year 2013

• Company report
• April 2013
• 6 pages

... The has been widely hailed as a victory for domestic manufactus, particularly generic drug producers. generic drugs are those that are introduced after patents expire on their original formulations ...

• Industries: Generic Drug
• Countries: India

Company Report: Generic Drug in The United States for Year 2013

• Company report
• April 2013
• 23 pages
• by Research Paper

... Discipline a significant decrease in profit margins on generic drugs or a failure to successfully launch a specialty drug after significant expense may lower our target price. A repeal or change ...

• Industries: Generic Drug
• Countries: United States

U.S. Generic Drug Business : Innovation and Technology Trends

• Industry report
• April 2013
• 9 pages
• by Research Paper

... As a generic drug can usually capture about 80% of the market at 20% of the branded price. Increased competition will benefit generic manufactus as they have significantly less research and development ...

• Industries: Generic Drug
• Countries: United States

Generic Drug Industry Overview

• Industry report
• March 2013
• 33 pages

• Industries: Generic Drug

Company Report: Generic Drug in India for Year 2013

• Company report
• March 2013
• 6 pages
• by Corporation

... And the industry would revert to a growth of 13-14% over the medium-term as structural growth drivers remain intact. The government S pro-generic initiatives may not also impact the industry structure at least ...

• Industries: Generic Drug
• Countries: India

Company Report: Generic Drug in India for Year 2013

• Company report
• March 2013
• 3 pages

• Industries: Generic Drug
• Countries: India

Glenmark Pharmaceuticals Ltd. - Company Report for Year 2013

• Company report
• March 2013
• 3 pages

• Industries: Generic Drug
• Countries: India, United States

Generic Drug in The United States : Innovation and Technology Trends

• Industry report
• March 2013
• 12 pages

... Of america and gpha, argue that settlements in patent cases reduce litigation time and costs and are pro-consumer because they ensure that lower-cost generic drugs come to market before patents expire ...

• Industries: Generic Drug
• Countries: United States

Company Report: Generic Drug in The United States for Year 2013

• Company report
• February 2013
• 5 pages

... Changes in the united states are likely to bring changes to the global api industry, experts say. Fda S generic drug user fee amendments of 2012 (gdufa) be- came effective on 1 october of that year ...

• Industries: Generic Drug
• Countries: United States

Company Report: Generic Drug in India and The United States for Year 2013

• Company report
• February 2013
• 2 pages
• by Corporation

... Manufacturing operations and strategy, quality, supply chain, sourcing, packaging and medical affairs, as well as the sales and marketing of mylan's generics business. Malik has held important leadership ...

• Industries: Generic Drug
• Countries: India, United States

Generic Drug Business in Europe, Brazil and The United States

• Industry report
• February 2013
• 10 pages

• Industries: Generic Drug
• Countries: Europe, Brazil, United States

Generic Drug Market in Europe

• Industry report
• February 2013
• 26 pages

• Industries: Generic Drug
• Countries: Portugal, Europe

Generic Drug Business Brief

• Industry report
• February 2013
• 32 pages

... Hale & tempest how to provide affordable medicines in today S competitive global market dr. Brian w tempest www.Briantempest.Com world generic medicines congress london ...

• Industries: Generic Drug

Generic Drug Market in Europe

• Industry report
• January 2013
• 17 pages

... generic medicines industry faces strong competition from trional producers such as the us and japan, along with growing competition from fast developing emerging market economies from the brick7 ...

• Industries: Generic Drug
• Countries: Europe

Company Report: Generic Drug in South Korea for Year 2013

• Company report
• January 2013
• 16 pages

... Accounted for 15.1% Of the generic drug market (as of 4q12), followed by cj (13.5%), Hanmi (4.7%), Shinpoong (4.0%), And ilong (3.2%). Recommend yuhan as top pick; ckd maintained as second-preferred stock ...

• Industries: Generic Drug
• Countries: South Korea

Watson Pharmaceuticals Inc. - Company Report for Year 2013

• Company report
• January 2013
• 3 pages

... Usa, and international headquarters in zug, switzerland. Actavis is the world's third-largest generics prescription drug manufactu. Operating as actavis pharma, the company develops, manufactures ...

• Industries: Generic Drug
• Countries: United States

Generic Drug Sector in China

• Industry report
• January 2013
• 2 pages
• by Trade Association

... Or manufacturing differences in biologics can result in significant safety differences in and/or effectiveness. Thirdly, the physician and patient should make treatment s. Small molecule generic drugs can ...

• Industries: Generic Drug
• Countries: China

Watson Pharmaceuticals Inc. - Company Report for Year 2013

• Company report
• January 2013
• 3 pages

... Usa, and international headquarters in zug, switzerland. Actavis is the world's third-largest generics prescription drug manufactu. Operating as actavis pharma, the company develops, manufactures ...

• Industries: Generic Drug
• Countries: United States

The Indonesian Generic Drug Business : Innovation and Technology Trends

• Industry report
• January 2013
• 3 pages

... A positive impact to the development of indofarma S non-generic drugs. Indofarma wants to increase non-generic drug sales by 20%, such as nutritional, herbal, otc, and anesthesia products. Person quoted ...

• Industries: Generic Drug
• Countries: Indonesia

Teva Pharmaceutical Industries Ltd. - Company Report for Year 2012

• Company report
• December 2012
• 2 pages
• by Corporation

... Issuer rating of a-, with a stable outlook. The credit rating agency said that the rating reflects teva S strategic position as the world's largest generic drug manufactu, financial discipline ...

• Industries: Generic Drug
• Countries: United States, Israel

Generic Drug Sector in Japan

• Industry report
• December 2012
• 20 pages

... For stable supply of generics as for compliance with the stable supply of generics, mhlw has set three requirements for generic medicines companies in 2006: At least five-year supply continuity ...

• Industries: Generic Drug
• Countries: Japan

Glenmark Pharmaceuticals Ltd. - Company Report for Year 2012

• Company report
• December 2012
• 3 pages
• by Corporation

• Industries: Generic Drug

World Generic Drug Industry Overview

• Industry report
• December 2012
• 36 pages

... Growth outlook moderate with generic penetration already over 80% Europe: impact of crisis on demand Increasing competition from lower cost providers accelerating price erosion Global pricing ...

• Industries: Generic Drug
• Countries: India, Asia, World

Global Generic Drug Sector Overview

• Industry report
• December 2012
• 28 pages

... Of international competition 20 year patent + up to 5 year spc leading countries in number of cans for biosimilars european generic medicines industry: major contributor to employment ...

• Industries: Generic Drug
• Countries: Europe, World

Global Generic Drug Sector Overview

• Industry report
• December 2012
• 27 pages

• Industries: Generic Drug
• Countries: World

Generic Drug Sector in Europe

• Industry report
• December 2012
• 32 pages

... generic medicines company source: ega and ec - sector inquiry unsustainable challenge more regulation/ increased costs price decrease national level national + eu level 26 positive trends ...

• Industries: Generic Drug
• Countries: Europe